Difluprednate increases IOP in cases of persistent hypotony

CHICAGO — Topical difluprednate did increase IOP when used as monotherapy in eyes with persistent hypotony after treatment for proliferative vitreoretinopathy, a speaker here said.
“Large retinectomies that we make during PVR repair can expose more [retinal pigment epithelium], more choroid, more sclera, which gives you increased aqueous outflow. More uveal scleral outflow causes post PVR repair hypotony,” Tarek S. Hassan, MD, said at Retina Subspecialty Day preceding the American Academy of Ophthalmology annual meeting. “Attempts recently to treat post-PVR repair

Full Story →